As members are aware, Pharmexcil has been assisting the members on various issues related to DGFT, Customs, Central Excise, DCGI, Drug regulatory procedures in overseas countries, market reports of various countries etc. Apart from assisting the members, Council has also been providing inputs to Government of India on various issues relating to pharma exports. While Secretariat of Council has been pooling up various sources for getting the information and extend services to both members and Government of India, sometimes it would be difficult to find the right source to get required information.
Keeping this in view, Committee of Administration has formed following Panels to ensure inputs to Secretariat on important issues whenever required and also to ensure proper representation of all the sectors in the Committee of Administration:
Sl. No.
|
Name of the Panel
|
Chief of the Panel
|
Contact details of Panel Chief
|
01.
|
Foreign Trade – DGFT, Direct & Indirect Taxes
|
Sri D B Mody
|
Email: dbmody@jbcpl.com
Phone: 022-24974159
|
02.
|
SME Panel
|
Sri Nipun Jain
|
Email: nipun@phrmchem.net
Phone: 011-45733494
|
03.
|
AYUSH Panel
|
Sri Ranjit Puranik
|
Email: rap@sdlindia.com
Phone: 022-30036300
|
04.
|
APIs/CROs/R&D/Clinical Trials/Legal/IPR Panel
|
Sri Madan Mohan Reddy
|
Email: mmreddy@aurobindo.com
Phone: 040-23044074
|
05.
|
Merchant Trade
|
Sri Devang Shah
|
Email: sales@aadivighnesh.com
Phone: 022-28926417
|
06.
|
Bio Pharma
|
*
|
*
|
07.
|
Medical Devices
|
Sri Ajay Pitre
|
*
|
( * These details will be informed separately)
We request the members who are interested to join as members of above panels and contribute on the relevant subjects, may write to the respective Panel Chief, with a copy to us, indicating their interest.
We also wish to inform that the above information will be placed in our website www.pharmexcil.com and members may communicate with respective Panel Chiefs for any clarifications on the subjects falling under their Panel.
We advise members to make note of this important development and contribute to the growth of pharma industry by joining as members of Panels. |